{
    "2021-04-23": [
        [
            {
                "time": "",
                "original_text": "【权益变动】泰格医药(03347-HK)获贝莱德增持11.9065万股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "贝莱德",
                        "增持",
                        "权益变动"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "泰格医药今日大宗交易成交13万股，成交价155.75元溢价0.0%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "大宗交易",
                        "成交价",
                        "溢价"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "【异动股】泰格医药(03347-HK)涨5.24%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "异动股",
                        "涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "CRO"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "基金换打法：降仓位、填洼地、抓龙头",
                "features": {
                    "keywords": [
                        "基金",
                        "换打法",
                        "降仓位",
                        "填洼地",
                        "抓龙头"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【异动股】CRO板块拉升，美迪西(688202-CN)涨4.12%",
                "features": {
                    "keywords": [
                        "CRO板块",
                        "拉升",
                        "美迪西",
                        "涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "CRO"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}